PHASE I EVALUATION OF SODIUM STIBOGLUICONATE

$48,715M01FY2006RRNIH

Cleveland Clinic Lerner Com-Cwru, Cleveland OH

Investigators

Ernest C. Bordencontact

Linked publications & trials

Paper 36946148 Paper 36940238 Paper 36822683 Paper 36066606 Paper 33323476 Paper 32984918 Paper 32795586 Paper 31142515 Paper 27270458 Paper 25966363 Paper 25680415 Paper 25418030 Paper 24677760 Paper 24589344 Paper 23541324 Paper 22895804 Paper 22745307 Paper 22694930 Paper 22070912 Paper 21940659 Paper 21397937 Paper 21302295 Paper 21258008 Paper 21145805 Paper 20443830 Paper 20227754 Paper 20217955 Paper 20200305 Paper 20133930 Paper 20123043 Paper 20074275 Paper 20029383 Paper 19936853 Paper 19906790 Paper 19892860 Paper 19816414 Paper 19614598 Paper 19585618 Paper 19580717 Paper 19531640 Paper 19521352 Paper 19520904 Paper 19506220 Paper 19501329 Paper 19360015 Paper 19351807 Paper 19304742 Paper 19164269 Paper 18995215 Paper 18849561 Paper 18725491 Paper 18675219 Paper 18640394 Paper 18635886 Paper 18510618 Paper 18323464 Paper 18258847 Paper 18237602 Paper 18208975 Paper 18191414 Paper 18083367 Paper 18078015 Paper 18070944 Paper 18068044 Paper 18049472 Paper 18045724 Paper 18032523 Paper 18022700 Paper 17991792 Paper 17971439 Paper 17967979 Paper 17935768 Paper 17828273 Paper 17721545 Paper 17709400 Paper 17693621 Paper 17689283 Paper 17676061 Paper 17664185 Paper 17662084 Paper 17653094 Paper 17576629 Paper 17572253 Paper 17526595 Paper 17494744 Paper 17475878 Paper 17468446 Paper 17428897 Paper 17427920 Paper 17339865 Paper 17291857 Paper 17289483 Paper 17268210 Paper 17145556 Paper 17124344 Paper 17112991 Paper 17103170 Paper 17101731 Paper 16963226 Paper 16951338

View original record on NIH RePORTER →